Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

ASCO 2018 - Validation of the efficacy of trabectedin in metastatic soft tissue sarcomas

back to job offer list
back to clinical trials

Villejuif, monday 4 june 2018
ASCO 2018

Validation of the efficacy of trabectedin in metastatic soft tissue sarcomas

On Monday 4 June, in an oral session of the Congress of the American Society of Clinical Oncology (Asco) in Chicago, Professor Axel Le Cesne, Medical Oncologist at Gustave Roussy, is presenting the results of the T – SAR study. This is a multicentre study comparing trabectedin with best supportive care in patients with metastatic soft tissue sarcomas.

ASCO 2018 - Les résultats du projet AcSé - crizotinib présentés au congrès de l’ASCO 2018 ouvrent la voie à de nouvelles indications dans plusieurs cancers

back to job offer list
back to clinical trials

Villejuif, le 1er juin 2018
ASCO 2018

Actualité lancement des ateliers Rose Danse à Gustave Roussy
05/30/2018

De la danse pour mieux vivre le cancer

Dans le cadre du programme Mieux Vivre le Cancer de Gustave Roussy, de nouveaux ateliers de danse sont proposés à nos patientes atteintes d'un cancer du sein ou gynécologique en fin de traitement.

Les Bonnes Fées et Maeva Coucke inaugurent les ateliers Rose Danse à Gustave Roussy

back to job offer list
back to clinical trials

Villejuif, le 29 mai 2018

Gustave Roussy at ASCO 2018 - Videos

back to job offer list
back to clinical trials

 

 

ASCO 2018 - Press releases

back to job offer list
back to clinical trials

ASCO 2018 Press releases

Gustave Roussy at ASCO 2018

back to job offer list
back to clinical trials

Gustave Roussy at ASCO 2018

As in every year for more than half a century, the world's leading Oncologists are meeting in Chicago early in June to discuss the latest clinical advances in the field. Gustave Roussy will, of course, be among the main protagonists at this Congress.

05/22/2018

Psycho-oncologie : des dispositifs pour tous

L'unité de psycho-oncologie de Gustave Roussy intervient auprès des patients - adultes et enfants - et de leurs proches, pour prévenir et traiter les répercussions négatives de la maladie sur leur quotidien. 

Death of Professor Thomas Tursz

back to job offer list
back to clinical trials

Villejuif, May 3rd, 2018

PEP-Therapy, Institut Curie and Gustave Roussy obtain 2,9 M€ to develop a novel peptide in oncology

back to job offer list
back to clinical trials

Paris and Villejuif (France), 17 April 2018,

PEP-Therapy, Institut Curie and Gustave Roussy obtain 2,9 M€ to develop a novel peptide in oncology

PEP-Therapy, Institut Curie and Gustave Roussy join together to conduct the Clever-Peptide project.

It aims at the development of an innovative anti-cancer peptide, firstly for the treatment of triple-negative breast cancer, and its companion biomarker, predictive of treatment efficacy. Approved by the Medicen Paris Region cluster, this collaborative project obtains 2,9 M€ funding.

Pages